EP1983000
Aðferð við að meðhöndla heila- og mænusigg með hamlandi IL-17 virkni
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
16.11.2004EP published:
2.9.2015EP application number:
08008814.9
EP translation filed:
16.11.2015Grant published:
15.12.2015EPO information:
European Patent Register
Max expiry date:
15.11.2024Expiry date:
15.11.2021
Title:
Method for the treatment of multiple sclerosis by inhibiting IL-17 activity
Timeline
Today
16.11.2004EP application
2.9.2015EP Publication
16.11.2015Translation submitted
15.12.2015Registration published
15.11.2021Expires
Owner
Name:
UCB Biopharma SPRLAddress:
Allée de la Recherche 60, 1070, Brussels, BE
Inventor
Name:
Christie, Mark IanAddress:
SloughBerkshire SL1 3WE, GB
Name:
Mead, Richard JamesAddress:
SloughBerkshire SL1 3WE, GB
Name:
Robinson, Martyn KimAddress:
SloughBerkshire SL1 3WE, GB
Name:
Rapecki, Stephen EdwardAddress:
SloughBerkshire SL1 3WE, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0327181Date:
21.11.2003Country:
GB
Number:
0417115Date:
30.7.2004Country:
GB
Classification
Categories:
A61K 38/17, A61K 39/395, A61K 47/48, A61P 37/00, C07K 16/24, C07K 16/28
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 17.11.2015
Expires: 15.11.2016
Payer: Árnason Faktor
Number: 13
Paid: 13.10.2016
Expires: 15.11.2017
Payer: Árnason Faktor
Number: 14
Paid: 5.10.2017
Expires: 15.11.2018
Payer: Árnason Faktor
Number: 15
Paid: 5.10.2018
Expires: 15.11.2019
Payer: Árnason Faktor
Number: 16
Paid: 8.10.2019
Expires: 15.11.2020
Payer: Árnason Faktor
Number: 17
Paid: 6.10.2020
Expires: 15.11.2021
Payer: Árnason Faktor ehf.